Simon Tsang, PhD
Chief Business Officer
Simon Tsang is a senior executive and advisor with over 20 years of broad and deep experience across big pharma, biotech, startups, and venture capital. Known for building many companies and portfolios through strategic planning, selective deal-making, and efficient integration, he partners with entrepreneurs to pursue disruptive technologies and business models. Simon has successfully led projects in research/pipeline strategy, platform partnering, indication split deals, international expansion, strategic clinical collaborations, spinouts, royalty sales, co-promotions, and M&A. His expertise spans pharmaceuticals, devices, and software across multiple therapeutic areas. Prior companies include Amgen, L.E.K. Consulting, Massachusetts General Hospital, MedImmune, Pivotal bioVenture Partners, and TESARO.
He has a Ph.D. in Biophysics from Harvard, where his thesis project involved finding a cure for the common cold.